6th June 2004 By Norah A A Al Khathlan M.D. JOURNAL CLUB A Comparison of High-Dose and Standard-dose Epinephrine in Children with Cardiac Arrest NEJM 350;17April.

Slides:



Advertisements
Similar presentations
Fluid Administration in the Management of DKA and Cerebral Oedema Journal Club 19th June 2014 Dr James West (ST7)
Advertisements

A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.
Carl Hinkson, MS, RRT-ACCS, NPS, FAARC Respiratory Care Department
prognosis of patients with Acute Myocardial Infarction remains dismal.
Journal Club General Medicine C- 4/3/14
EFFICACY AND SAFETY OF RECOMBINANT HUMAN ACTIVATED PROTEIN C FOR SEVERE SEPSIS (PROWESS) GORDONR. BERNARD, M.D. et al. The New England Journal of Medicine.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Journal Club Alcohol and Health: Current Evidence July-August 2006.
In a patient who has sustained blunt trauma who is found to have an occult pneumothorax on CT scan, is tube thoracostomy better than observation at reducing.
Materials and methods Sadeghi Ramin, MD Nuclear Medicine Research Center, Mashhad University of Medical Sciences.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Decreasing Hospital LOS for Bronchiolitis Sandweiss DR, Mundorff MB, Hill T, et al.
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial Journal Club 09/01/11 JAMA, February 4, 2009—Vol 301, No
OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.
Paediatric Resuscitation Guidelines 2005
Discussion Gitanjali Batmanabane MD PhD. Do you look like this?
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
Sarah Struthers, MD March 19, 2015
Journal Club by Dr Mohammad Al-Busafi R4.  Compare efficacy of  Ibuprofen 10 mg /kg  Paracetamol and codeine ( cocodamol ! ) 1mg/kg (codeine component.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Duality of interests B.M. Mayosi has received research grants from AstraZeneca, Cadila Pharma, Novartis, Pfizer, Roche, and Servier.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 8 – Comparing Proportions Marshall University Genomics.
Exam Exam starts two weeks from today. Amusing Statistics Use what you know about normal distributions to evaluate this finding: The study, published.
Consumer behavior studies1 CONSUMER BEHAVIOR STUDIES STATISTICAL ISSUES Ralph B. D’Agostino, Sr. Boston University Harvard Clinical Research Institute.
1 Statistical Review Dr. Shan Sun-Mitchell. 2 ENT Primary endpoint: Time to treatment failure by day 50 Placebo BDP Patients randomized Number.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Landmark Trials: Recommendations for Interpretation and Presentation Julianna Burzynski, PharmD, BCOP, BCPS Heme/Onc Clinical Pharmacy Specialist 11/29/07.
RBC transfusions in critically ill patients TMR Journal Club March 1, 2007 Maggie Constantine.
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:
UOG Journal Club: July 2013 Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis G. Pagani, F. D’Antonio,
A Randomised, Controlled Trial of Acetaminophen, Ibuprofen, and Codeine for Acute Pain relief in Children with Musculoskeletal Trauma Clark et al, Paediatrics.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
THE EFFECT OF TIMING OF INITITIATION OF CRRT ON PATIENTS REQUIRING EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) Asif Mansuri, MD, MRCPI Fellow, Division.
Why we don’t like protocol violations Yuko Y. Palesch, PhD Medical University of South Carolina.
How To Design a Clinical Trial
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
Indiaclen Short course of Amoxicillin in treatment of Pneumonia (ISCAP) 3 versus 5 days amoxicillin for treatment of non-severe pneumonia in young children:
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
What is the ideal chest compression:ventilation ratio?
Chicago 2014 Pediatric RRT/MET Teams #397 TFQO: Dianne Atkins COI #7 EVREV 1: Dianne Atkins EVREV 2: Kee Chong Ng COI #113 Taskforce: Peds.
Poster Design & Printing by Genigraphics ® A Comparison of the Effects of Etomidate and Midazolam on the Duration of Vasopressor Use in.
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)
1 Pulminiq™ Cyclosporine Inhalation Solution Pulmonary Drug Advisory Committee Meeting June 6, 2005 Statistical Evaluation Statistical Evaluation Jyoti.
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Jan-Thorsten Graesner COI #150 Taskforce: ALS ALS 783 : Advanced versus basic.
LINC Trial LUCAS in cardiac arrest trial. What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS.
Introduction Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation.
Do IV Meds Matter in Out-of-Hospital Cardiac Arrest? Summary and Comment by John A. Marx, MD, FAAEM Published in Journal Watch Emergency Medicine December.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Magnesium Sulfate in Severe Perinatal Asphyxia: A Randomized, Placebo-Controlled Trial Mushtaq Ahmad Bhat, et al Apr 6, 2009 Presented By: Yasser Al-Garni.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
From: PLOS Neglected Tropical DiseaseJanuary 2014 Presented by Pavitra Charoensrisakkul and Peeraya Permkarnjaroen 3 rd year medical cadet Phramongkutklao.
A pilot randomized controlled trial Registry #: NCT
Pharmacist Impact on Patient Mortality and Advanced Cardiac Life Support Guideline Compliance During In-Hospital Cardiac Arrest Joseph Cavanaugh, PharmD.
Angela Aziz Donnelly April 5, 2016
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Preoperative Anemia and Postoperative Mortality in Neonates Goobie SM, Faraoni D,
Sample Journal Club Your Name Here.
How To Design a Clinical Trial
CLINICAL PROTOCOL DEVELOPMENT
Interventional trials
Nottingham City Hospital, Critical Care Journal Club
Jeff Macemon Waikato Cardiothoracic Unit
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Chen S, Dong Y, Kiuchi MG, et al
What is LINC? A multicenter, randomized, controlled trial
B-FREE Trial B-FREE Trial Summary.
Presentation transcript:

6th June 2004 By Norah A A Al Khathlan M.D. JOURNAL CLUB A Comparison of High-Dose and Standard-dose Epinephrine in Children with Cardiac Arrest NEJM 350;17April 22, 2004

What is being studied ? The Study Objective: To compare the use of high-dose epinephrine 0.1mg/kg with standard-dose 0.01mg/kg for the 2 nd dose of epinephrine (i.e.,the rescue dose) during resuscitation following in-hospital cardiac arrest in children. Conducted at the Children’s institute: 122-bed tertiary care center. More than 6000 pts/yr. No trauma or cardiac surgery.

What is being studied ? Hypothesis: “ In children who had an in-hospital cardiac arrest, rescue therapy with high-dose epinephrine( HDE) as compared with continued use of the standard dose, would improve the rate of survival at 24 hrs.” “ the difference will be more clearly demonstrable in patients with asphyxia-precipitated arrests.”

What is being studied ? Study design: Prospective, randomized, double-blind trial. The trial included 68 children The primary outcome measure was survival 24hrs after the arrest.

What is being studied ? Inclusion criteria: All Children who remain in cardiac arrest despite CPR & an initial standard-dose of epinephrine (0.01mg/kg). All children as above between October 31,1999, to September 30, Only the initial cardiac arrest was evaluated if more than one occurred.

What is being studied ? Exclusion criteria: Neonates. Trauma cases. Those with cardiac arrests commencing outside the hospital. Those with DNR orders. Subsequent arrests.

What is being studied ? Definition of cardiac arrest: The cessation of mechanical cardiac activity, determined on the basis of the absence of a palpable pulse and the presence of unresponsiveness and apnea.

What is being studied ? Interventions compared: Patients who remained in cardiac arrest despite CPR and an initial standard-dose of epinephrine (0.01mg/kg) were randomized to receive:  Standard-dose epinephrine (0.01mg/kg/dose).  High-dose epinephrine (0.1mg/kg/dose).

What is being studied ? Outcome measured: Survival at 24hrs post cardiac arrest. Survivors were additionally followed post discharge for neurological deficits

Methods  Randomization was provided by computer: “random-number generator”  Single pharmacist prepared treatment packages: Each with 10 x 1ml vials of epinephrine in a solution of 1: 1000 or 1:  Patients who remained in cardiac arrest after CPR & 1 st dose of epinephrine “routinely stocked”, received 0.1ml/kg of the experimental solution which provided :  0.01mg/kg/dose if it was of 1:10000 solution.  0.1mg/kg/dose if it was of 1:1000 solution.

Methods  All further doses were provided from the same treatment package.  Only the study pharmacist had access to information pertaining to concentration of epinephrine used.  CPR team provided CPR as per AHA guidelines without interference from research team.

Methods Ethical issues: The study was exempted from the requirement of an informed consent because of: The unexpected & sudden nature of cardiac arrests. Both dose strategies are recommended by AHA. An informed consent was required & obtained for continued follow-up after discharge.

Methods Sample size: Previous experience: 2 year period expected to yield approximately 70 patients. 24 hrs survival after 2 standard doses of epinephrine was ~ 20%. 24 hrs survival after rescue therapy with high-dose epinephrine increased from 0% to 50%. With 34 patients in each group the power to detect an improvement from 20 to 50 % was 75%.

Methods  Statistical analysis:  Intention to treat basis.  1ry outcome was 24hrs survival.  Data from patients with arrests 2ry to asphyxia and those from arrests 2ry to shock were analysed separately.  StatView 5.0 & Stata 7.0 software.  Chi-square analysis or Fisher’s exact test for disrete variables and unpaired t-tests for continuous variables.  All reported P values are two-sided.  Multiple logistic-regression analysis were used for differences between groups.  Some protocol violation still occurred requiring further analysis.

Results  185 patients with cardiac arrests.  117 met exclusion criteria.  67 cases due to DNR orders.  68 children were enrolled & randomly assigned to:  High-dose treatment regimen (34 patients).  Standard-dose regimen (34 patients).  Protocol violations in 18 of 68 cases.  The two groups were generally similar before arrest.

Results  Protocol violations In 18 out of 68 cases:  10 cases had deviations from recommended doses.  3 in the standard-dose group.  7 in the high-dose group.  Doses ranged between to 0.06mg/kg/dose.  8 cases of the standard-dose group were given high doses at some point.  7 of these were > 20kg  used up the experimental dose!

Results In general:  Prior to arrest:  Nearly all arrests, 96% were witnessed.  78% were on cardiac monitors.  68% were on ventilators.  53% were with Catecholamine infusions.  During resuscitation:  More patients in high-dose group received 2-3 doses. (19 vs. 11).  More in standard-dose received > 6 doses. ( 12 vs. 5).  Both findings were statistically significant P value 0.05

Results  Rate of survival at 24 hrs was lower in HDE group, P=0.05 (C.I ) However the above refers to “unadjusted odds ratio” !!  After adjustment by multiple logistic-regression analysis for differences between the 2 treatments …..difference is not statistically significant P=0.08 (C.I ).

Results  None of the HDE group survived to hospital discharge as compared with 4 of the 34 in SDE group. P = 0.11 But… “ the two treatment groups did not differ significantly in terms of ROSC or the rate of survival to hospital discharge”.

Results Separate analysis for those with asphyxia related arrests.  For those with asphyxia related arrests n= 30 :  none of the 12 in HDE survived at 24hrs.  7 out of 18 in SDE survived at 24hrs. P =0.02  38 patients had arrests precipitated by shock  22 in HDE  16 in SDE

Results Analysis after exclusion of all protocol violations:  Survival is lower in HDE 1 of 27  as compared to 6 of 23 in SDE  P =0.04 Is this an acceptable way of analysis?

Results  Of those with “no protocol violations” and arrests precipitated by asphyxia:  24 hrs survival in HDE group (0 of 8).  6 of 13 in SDE group.  P = 0.04

Finally….weaknesses!!  Small sample size:  Power of 75%  Unacceptable.  C.I.  Protocol violations:  Contamination. ? bias  Population studied:  monitored & witnessed arrests.  no cardiac disease